Challenges in the Development of Drugs for Sarcopenia and Frailty - Report from the International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force

Sarcopenia and frailty represent two burdensome conditions, contributing to a broad spectrum of adverse outcomes. The International Conference on Frailty and Sarcopenia Research (ICFSR) Task Force met virtually in September 2021 to discuss the challenges in the development of drugs for sarcopenia an...

Descripción completa

Detalles Bibliográficos
Autores principales: Cesari, Matteo, Bernabei, R., Vellas, B., Fielding, R. A., Rooks, D., Azzolino, D., Mariani, J., Oliva, A. A., Bhasin, S., Rolland, Y.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2022
Materias:
ICFSR Task Force Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017069/
https://www.ncbi.nlm.nih.gov/pubmed/35441189
http://dx.doi.org/10.14283/jfa.2022.30

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9017069/
https://www.ncbi.nlm.nih.gov/pubmed/35441189
http://dx.doi.org/10.14283/jfa.2022.30

Ejemplares similares